- ASSOCIATE CLINICAL PROFESSOR Obstetrics, Gynecology and Reproductive Science
Dr. Herbert Gretz is an Associate Clinical Professor and the Director of the Gynecologic Minimally Invasive Surgery Division and Director of the Minimally Invasive Fellowship in the Department of Obstetrics, Gynecology and Reproductive Science. Dr Gretz completed his Fellowship in Gynecologic Oncology at the University of Michigan Medical Center. He was an Assistant Professor at the Weill Cornell Medical School and an Attending Physician at New York Presbyterian Hospital from 1993 thur 1999. He then joined the Mount Sinai School of Medicine. Dr Gretz is known throughout the New York metropolitan region as a highly skilled surgeon with unique laparoscopic abilities. Dr Gretz oversees the training of residents and fellows in gynecologic oncology and gynecologic minimally invasive surgery.
Gad MS, El Khouly NI, Soto E, Brodman M, Chuang L, Nezhat FR, Gretz HF. Differences in perioperative outcomes after laparoscopic management of benign and malignant adnexal masses. Journal of gynecologic oncology 2011 Mar; 22(1).
Soto E, Lo Y, Friedman K, Soto C, Nezhat F, Chuang L, Gretz H. Total laparoscopic hysterectomy versus da Vinci robotic hysterectomy: is using the robot beneficial?. Journal of gynecologic oncology 2011 Dec; 22(4).
Nezhat FR, DeNoble SM, Liu CS, Cho JE, Brown DN, Chuang L, Gretz H, Saharia P. The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons; 14(2).
Nezhat FR, Ezzati M, Chuang L, Shamshirsaz AA, Rahaman J, Gretz H. Laparoscopic management of early ovarian and fallopian tube cancers: surgical and survival outcome. American journal of obstetrics and gynecology 2009 Jan; 200(1).
Gretz H, Bradley WH, Zakashansky K, Nezhat F, Rahaman J, Chuang L, Bohren DL, Kreiger K, Rubin E, Sokolow A. Patient clinical factors influencing use of hysterectomy in New York, 2001-2005. American journal of obstetrics and gynecology 2008 Oct; 199(4).
Gretz H, Bradley WH, Zakashansky K, Nezhat F, Bohren DL, Kreiger K, Rubin E, Sokolow A. Effect of physician gender and specialty on utilization of hysterectomy in New York, 2001-2005. American journal of obstetrics and gynecology 2008 Oct; 199(4).
Nezhat F, Yadav J, Rahaman J, Gretz H, Cohen C. Analysis of survival after laparoscopic management of endometrial cancer. Journal of minimally invasive gynecology; 15(2).
Nagarsheth NP, Rahaman J, Cohen CJ, Gretz H, Nezhat F. The incidence of port-site metastases in gynecologic cancers. JSLS : Journal of the Society of Laparoendoscopic Surgeons / Society of Laparoendoscopic Surgeons; 8(2).
Nezhat F, Yadav J, Rahaman J, Gretz H, Gardner GJ, Cohen CJ. Laparoscopic lymphadenectomy for gynecologic malignancies using ultrasonically activated shears: analysis of first 100 cases. Gynecologic oncology 2005 Jun; 97(3).
Zakashansky K, Chuang L, Gretz H, Nagarsheth NP, Rahaman J, Nezhat FR. A case-controlled study of total laparoscopic radical hysterectomy with pelvic lymphadenectomy versus radical abdominal hysterectomy in a fellowship training program. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society; 17(5).
Slomovitz BM, Caputo TA, Gretz HF, Economos K, Tortoriello DV, Schlosshauer PW, Baergen RN, Isacson C, Soslow RA. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. The American journal of surgical pathology 2002 May; 26(5).
Saini J, Kuczynski E, Gretz HF, Sills ES. Supracervical hysterectomy versus total abdominal hysterectomy: perceived effects on sexual function. BMC women's health 2002; 2(1).
Sills ES, Saini J, Steiner CA, McGee M, Gretz HF. Abdominal hysterectomy practice patterns in the United States. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 1998 Dec; 63(3).
Argenta PA, Rahaman J, Gretz HF, Nezhat F, Cohen CJ. Vacuum-assisted closure in the treatment of complex gynecologic wound failures. Obstetrics and gynecology 2002 Mar; 99(3).
Dattoli MJ, Gretz HF, Beller U, Lerch IA, Demopoulos RI, Beckman EM, Fried PR. Analysis of multiple prognostic factors in patients with stage IB cervical cancer: age as a major determinant. International journal of radiation oncology, biology, physics 1989 Jul; 17(1).
Sills ES, Saini J, Applegate MS, McGee M, Gretz HF. Supracervical and total abdominal hysterectomy trends in New York State: 1990-1996. Journal of urban health : bulletin of the New York Academy of Medicine 1998 Dec; 75(4).
Chuang LT, Moqattash ST, Gretz HF, Nezhat F, Rahaman J, Chiao JW. Sulforaphane induces growth arrest and apoptosis in human ovarian cancer cells. Acta obstetricia et gynecologica Scandinavica 2007 Jul;.
Fields A, Hochster H, Runowicz C, Speyer J, Goldberg G, Cohen C, Dottino P, Wadler S, Berk G, Gretz H, Mandeli J, Holland J, Letvak L. PSC833: initial clinical results in refractory ovarian cancer patients. Current opinion in oncology 1998 Aug; 10 Suppl 1.
Gretz HF, Talavera F, Connor P, Pearl M, Lelle RJ, Roberts JA, Menon KM. Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLE. Gynecologic oncology 1994 May; 53(2).
Soto E, Soto C, Nezhat FR, Gretz HF, Chuang L. Chylous ascites following robotic lymph node dissection on a patient with metastatic cervical carcinoma. Journal of gynecologic oncology 2011 Mar; 22(1).
Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 2002 Jun; 94(11).
Pearl ML, Talavera F, Gretz HF, Roberts JA, Menon KM. Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE. Gynecologic oncology 1993 Jun; 49(3).
Lelle RJ, Talavera F, Gretz H, Roberts JA, Menon KM. Epidermal growth factor receptor expression in three different human endometrial cancer cell lines. Cancer 1993 Jul; 72(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Gretz is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Klingenstein Pavillion Floor 9
1176 Fifth Avenue
New York, NY 10029
1150 Fifth Avenue
New York, NY 10129
Dickstein Cancer Center
2 Longview Avenue, Suite 302
White Plains, NY 10601